Ultragenyx Pharmaceutical Inc. (RARE) EPS (Basic) (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) reported EPS (Basic) of -$0.90 for Q2 2026, compared with -$1.17 a year earlier.
Ultragenyx Pharmaceutical Inc. (RARE) EPS (Basic) (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ultragenyx Pharmaceutical's EPS (Basic) came in at -$5.75; for FY2025, it came in at -$5.83.
- By year, EPS (Basic) came in at -$6.28 in FY2024, -$8.25 in FY2023, -$10.12 in FY2022 and -$6.70 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly EPS (Basic) since Q4 2020.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$1.84 (Q1 2026), -$1.30 (Q4 2025) and -$1.81 (Q3 2025).
Peer Comparison
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.90 |
| Mar 31, 2026 | -1.84 |
| Dec 31, 2025 | -1.30 |
| Sep 30, 2025 | -1.81 |
| Jun 30, 2025 | -1.17 |
| Mar 31, 2025 | -1.57 |
| Dec 31, 2024 | -1.47 |
| Sep 30, 2024 | -1.40 |
| Jun 30, 2024 | -1.52 |
| Mar 31, 2024 | -2.03 |
| Dec 31, 2023 | -1.68 |
| Sep 30, 2023 | -2.23 |
| Jun 30, 2023 | -2.25 |
| Mar 31, 2023 | -2.33 |
| Dec 31, 2022 | -2.17 |
| Sep 30, 2022 | -3.50 |
| Jun 30, 2022 | -2.26 |
| Mar 31, 2022 | -2.19 |
| Dec 31, 2021 | -1.81 |
| Sep 30, 2021 | -1.08 |
Ultragenyx Pharmaceutical Inc. EPS (Basic) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-basic&ticker=RARE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-basic", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=eps-basic&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();